EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Clinical and Laboratory Factors Associated with Serious Infections in Multiple Myeloma: A Real-World Study

Aslı Odabaşı Giden iD, Onur Şahin iD, Duzgun Ozatli

Current Oncology · 2026

DOI: 10.3390/curroncol33100615 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Current Oncology, 2026. Verfasst von Aslı Odabaşı Giden und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Ordu State Hospital, Ordu 52200, Turkey. Hauptthemen laut MEDLINE: Infections, Multiple Myeloma. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BERK İLAÇ İTHALAT VE PAZARLAMA A.Ş.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Serious infections remain a major cause of morbidity and treatment disruption in patients with multiple myeloma (MM). Identifying readily available clinical factors associated with infectious complications may facilitate risk-adapted supportive care. This study evaluated clinical and laboratory factors associated with serious infection in patients with MM, including the potential association of baseline neutrophil-to-lymphocyte ratio (NLR) with subsequent serious infectious complications.

Methods

This retrospective multicenter cohort study included 104 patients with MM. Baseline demographic, disease-related, treatment-related, and laboratory characteristics were evaluated. Serious infection was defined as an infectious episode requiring hospitalization. Infectious events were recorded throughout follow-up, including those occurring during second-line and subsequent therapies. Associations with serious infection were assessed using univariate and multivariable binary logistic regression analyses. The primary multivariable model included age, International Staging System (ISS) stage, dialysis requirement at diagnosis, treatment response, and baseline NLR.

Results

Serious infections occurred in 39 patients (37.5%). Dialysis requirement at diagnosis (30.8% vs. 4.6%, p = 0.001), failure to achieve treatment response (51.3% vs. 7.7%, p < 0.001), hypogammaglobulinemia (48.7% vs. 29.2%, p = 0.046), and IVIG administration (76.9% vs. 46.2%, p = 0.002) were more frequent among patients with serious infection. Baseline NLR did not differ significantly between patients with and without serious infection. In the multivariable model, dialysis requirement at diagnosis (adjusted OR 8.26, 95% CI 1.81–37.68; p = 0.006) and failure to achieve treatment response (adjusted OR 16.77, 95% CI 4.37–64.31; p < 0.001) were independently associated with serious infection, whereas age, ISS stage, and baseline NLR were not.

Conclusions

Serious infections were common in this real-world MM cohort. Dialysis requirement at diagnosis and failure to achieve treatment response were independently associated with serious infection, whereas baseline NLR was not independently associated with serious infectious complications. These findings suggest that clinical characteristics reflecting renal dysfunction and treatment response may be useful for identifying patients at increased risk of serious infection. The observed association between IVIG administration and serious infection should be interpreted cautiously because of potential confounding by indication and reverse causality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InfectionsMultiple MyelomaAgedFemaleHumansMaleMiddle AgedNeutrophilsRetrospective StudiesRisk Factors

Stichwörter der Autor:innen

dialysisintravenous immunoglobulinmultiple myelomaneutrophil-to-lymphocyte ratioserious infectiontreatment response

Autor:innen und Institutionen

  • Department of Hematology, Ordu State Hospital, Ordu 52200, Turkey.
  • Department of Hematology, Ondokuz Mayıs University, Samsun 55139, Turkey.

ORCID-Profile: Aslı Odabaşı Giden, Onur Şahin

Förderung

  • BERK İLAÇ İTHALAT VE PAZARLAMA A.Ş

Zitieren

APA

Odabaşı Giden, A., Şahin, O., & Ozatli, D. (2026). Clinical and Laboratory Factors Associated with Serious Infections in Multiple Myeloma: A Real-World Study. Current Oncology. https://doi.org/10.3390/curroncol33100615

Vancouver

Odabaşı Giden A, Şahin O, Ozatli D. Clinical and Laboratory Factors Associated with Serious Infections in Multiple Myeloma: A Real-World Study. Current Oncology. 2026. doi:10.3390/curroncol33100615

BibTeX
@article{OdabaGiden2026,
  author = {Odabaşı Giden, Aslı and Şahin, Onur and Ozatli, Duzgun},
  title = {Clinical and Laboratory Factors Associated with Serious Infections in Multiple Myeloma: A Real-World Study},
  journal = {Current Oncology},
  year = {2026},
  doi = {10.3390/curroncol33100615}
}
Kostenlos starten →